To aid surgical and healing process in patients, Brookes Pharmaceuticals in collaboration with Pharmaplus Nigeria Limited has unveiled Pyodine range of antiseptics into Nigerian pharma market.
The colourful ceremony which took place at Sheraton Hotel, Ikeja GRA, Lagos on 30 July 2019 had eminent pharmacists, nurses, doctors and several dignitaries in attendance.
In his welcome remarks, Pharm. Ahmed Yakasai, managing director, Pharmaplus Nigeria Limited explained that as a past president of the Pharmaceutical Society of Nigeria (PSN), he understands the importance of safety and quality assurance.
“It is not only about quality, the safety of patients should be utmost in the mind of every health worker,” he said.
Christened as the Consul General of Pakistan in Nigeria, Yakasai disclosed that his attention was drawn to the quality of pharmaceuticals in Pakistan by the late Director General of National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Dora Akunyili.
“With that in mind, I can confidently tell you that there is no better product range presently in the market than Pyodine. It is a broad spectrum antiseptic for wound care,” he stressed
In his address, Major Gen. Waqar Ahmad Kingravi (rtd), high commissioner of Pakistan to Nigeria congratulated both companies adding that in the whole of Pakistan, Brookes Pharma stands out as a leader in producing premium and affordable antiseptics.
“Beyond that, Pakistan is a vibrant country that boasts of great pharma companies. The industry is open for collaboration, deliberation and cooperation with pharma companies in Nigeria.
“Once again, I congratulate Yakasai and Brookes on this novel products unveiling and wish them all the best,” he remarked.
Appreciating the audience, Adnan Ali Khan, director, global business, Brookes Pharmaceuticals announced that he was pleased to visit Nigeria whose pharma industry he admires so much.
While reiterating that Brookes is into management of chronic wounds treatment, the director also declared that his company welcomes constructive criticism, suggestion and direction on ways to improve on the brands positively.
Other dignitaries in attendance included Santosh Kumar, managing director, Worldwide Commercial Ventures (WWCV); Pharm. Ade Popoola, managing director, Reals Pharmaceuticals; Sir Ifeanyi Atueyi, managing director, Pharmanews Limited; Pharm. Anthony Oyawole, former presidential aspirant, PSN; Adham Yehia, co-founder, DrugStoc Nigeria Limited; Dr Arif Siddiqui, advisor on regulatory & marketing affairs, Brookes Pharma; Pharm. Chibuzor Opara, co-founder, DrugStoc Nigeria Limited; Sandar Rahin, assistant secretary, commercial, Pakistan High Commission; Pharm. Margaret Obono, director of pharmacy and head of pharmacy department, National Orthopaedic Hospital, Igbobi and Tahir Abbas, commercial secretary, Pakistan High Commission.
Just like every success story, Brookes Pharma began with the establishment of a nascent pharmaceutical company based on a philosophy that regarded quality as the highest value in 1986.
It started out with production of injectible products – a segment that needs great sophistication of equipment and expertise. Brookes was also the first pharmaceutical of Pakistan to introduce research novelties for treatment of liver related diseases.